NCT00224692

Analgesic Effect in Children of Low-Dose Ketamine for Mucositis Treated by Patient-Controlled Analgesia With Morphine

MK III Trial: Analgesic Effect in Children of Low-Dose Ketamine for Mucositis Treated by Patient-Controlled Analgesia With Morphine

• Status: Terminated
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 50 (planned)
• Sponsor: Assistance Publique - Hôpitaux de Paris · Academic / Other
• Sex: All
• Age: 5 Years – 18 Years
• Healthy volunteers: Not accepted

Summary

Hypothesis : Low dose ketamine has an analgesic effect in children with mucositis treated by patient-controlled analgesia with morphine

Detailed description

Double blind versus placebo multicenter Phase III trial of kétamine in children with chemotherapy induced-mucositis treated by patient-controlled analgesia with morphine

Conditions

• Cancer
• Mucositis

Interventions

Type	Name	Description
DRUG	Low dose ketamine

Timeline

• Start date: 2003-02-01
• Completion: 2006-08-01
• First posted: 2005-09-23
• Last updated: 2006-10-26

Locations

1 site across 1 country: France